UrSure Patents – Insights & Stats (Updated 2023)

UrSure has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 75% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of UrSure.

UrSure was founded in 2015. UrSure produces medical devices that track and enhance drug adherence. It provides diagnostic testing, medication adherence, public health, social impact, healthcare, and medical devices.

Do read about some of the most popular patents of UrSure which have been covered by us in this article and also you can find UrSure patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over UrSure patent portfolio.

How many patents does UrSure have?

UrSure has a total of 12 patents globally. These patents belong to 3 unique patent families. Out of 12 patents, 9 patents are active.

How Many Patents did UrSure File Every Year?

UrSure Patent Filling Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantUrSure Applications FiledUrSure Patents Granted
20211
20203
20186
20172

How many UrSure patents are Alive/Dead?

Worldwide Patents

UrSure Patent Portfolio

How Many Patents did UrSure File in Different Countries?

UrSure Worldwide Patent Filing

Countries in which UrSure Filed Patents

CountryPatent
Japan1
Indonesia1
United States Of America1
Canada1
India1
China1
Singapore1
Europe1
Australia1
Hong Kong (S.A.R.)1

Where are Research Centers of UrSure Patents Located?

The Research Centers of UrSure Patents is the United States of America.

List of UrSure patents

UrSure PatentsTitle
EP3695225A4Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
CN111727372AProducts And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
AU2018347704A1Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
CA3079140A1Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
JP2020536588A5Products And Methods For Compliant Monitoring Of Nucleoside Reverse Transcriptase Inhibitor Therapy
HK40037026AProducts And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
ID2020PID03976AProducts And Methods For Monitoring Compliance In Nucleocides Return Transcription Inhibitor Therapy
IN202017019616AProducts And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
SG11202003318QAProducts And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy
US20200200735A9System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen
WO2020205897A1System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen
WO2017147186A1System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen

What are UrSure key innovation segments?

What Technologies are Covered by UrSure?

The chart below distributes patents filed by UrSure in different countries on the basis of the technology protected in patents. It also represents the markets where UrSure thinks it’s important to protect particular technology inventions.

R&D Focus: How has UrSure search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by UrSure?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.